
Manthanam Pharmaceutical Private Limited
About Manthanam Pharmaceutical Private Limited
Data last updated:
Manthanam Pharmaceutical Private Limited is a private limited company based in Raiganj, West Bengal, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2022PTC257175.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Raja Das and Samrat Bose.
Its last annual general meeting (AGM) was held on 30 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Samrat Bose Holding No 895/N Ward – 24 Collegepara Po & Ps Raiganj, West Bengal, India – 733134.
Manthanam Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-20-0008114). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Manthanam Pharmaceutical
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-WB-20-0008114
Contact details
Manthanam Pharmaceutical Private Limited's registered office is in Raiganj, West Bengal.
- Registered AddressC/O Samrat Bose Holding No 895/N Ward – 24 Collegepara Po & Ps Raiganj, West Bengal, India – 733134
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Manthanam Pharmaceutical Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Manthanam Pharmaceutical Private Limited, buy the company report.
Board of directors of Manthanam Pharmaceutical Private Limited
Manthanam Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raja Das | Director | 14 Sep 2022 | 4 Years 1 Months | Current |
| Samrat Bose | Director | 14 Sep 2022 | 4 Years 1 Months | Current |
| Arnab Mondal Also directs: Biswa Bangla Textiles and Handlooms Private Limited | Director | 14 Sep 2022 | 4 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Manthanam Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manthanam Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Manthanam Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Manthanam Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Arnab Mondal was appointed as Director on 14 Sep 2022.
Frequently asked questions
Manthanam Pharmaceutical is an active private limited company based in Raiganj, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2022 (4+ years old) and is registered under CIN U24100WB2022PTC257175.
Manthanam Pharmaceutical has 3 current directors:
- Raja Das - Director
- Samrat Bose - Director
- Arnab Mondal - Director
The latest financial statements of Manthanam Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 December 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Manthanam Pharmaceutical is U24100WB2022PTC257175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manthanam Pharmaceutical was incorporated on 14 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
Arnab Mondal was appointed as Director on 14 Sep 2022. Raja Das was appointed as Director on 14 Sep 2022. Samrat Bose was appointed as Director on 14 Sep 2022.
Yes, Manthanam Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Manthanam Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-20-0008114).
The registered office of Manthanam Pharmaceutical is at CO Samrat Bose Holding No 895N Ward – 24 Collegepara Po & Ps Raiganj, West Bengal, India – 733134.
Manthanam Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

